Full index of posts »
I just published an article on $NWBO. See this link. http://bit.ly/1M5v6Rx Oct 20, 2015
Cytokinetics: New Collaboration With Astellas On CK-2127107 Greatly Improves Investment Outlook http://seekingalpha.com/p/24u9p Dec 24, 2014
Neuralstem: Some Encouraging, But Very Early, Information On Chinese Ischemic Stroke Trial Using NSI-566... http://seekingalpha.com/p/24hf7 Dec 18, 2014
- Smith On Stocks on Discovery Laboratories: Results For Phase 2a Trial Are Quite Encouraging; Why Then Did The Stock Crash Phase 2b results on a 250 patient, randomized t...
- jackson0030 on Discovery Laboratories: Results For Phase 2a Trial Are Quite Encouraging; Why Then Did The Stock Crash I know investors who've lived and died holding ...
- BILLYJIMBOB1 on Northwest Biotherapeutics: Analysis Of A Coordinated Short Selling Attack Against The Stock This stock requires the utmost patience. Thanks...
- mike711 on Neuralstem: A Closer Look At Encouraging Phase 2 Results For NSI-566 Neural Stem Cells In Treating ALS (CUR, Buy, $2.36) Mr. Smith please comment on my thought concerni...
- sfrue on Comments On Data Presented By Northwest Biotherapeutics On DCVax Direct At ASCO Excellent presentation and read! Thank you, Smith.
- ADH on Washington Post Calls For An Investigation Into Hedge Fund Trading And Adam Feuerstein's Blogging Their Shorting Afrezza (Mankind Product) too; a...
- Northwest Biotherapeutics' DC Vax Cancer Vaccine May Be A Game Changer In Cancer Therapy ( Comments)
- If You're Going To San Francisco ( Comments)
- Neuralstem: Initial Take On Top Line Results Of Phase 2 ALS Trial Of NSI-566 Neural Stem Cells ( Comments)
- My Dialogue With Adam Feuerstein On Northwest Biotherapeutics ( Comments)
- Northwest Biotherapeutics (NWBO, $6.06, Buy): Comments On First Interim Look At DCVax-L Trial And Recent Weakness In The Stock ( Comments)